A phase I/II trial of neoadjuvant chemot
โ
Jean Viallet; Marc-Andrรฉ Brassard; Luis Souhami; Joseph Ayoub; Pierre Del Vecchi
๐
Article
๐
1999
๐
John Wiley and Sons
๐
English
โ 108 KB
๐ 2 views
## BACKGROUND. Both locoregional and distant disease control remains poor in the treatment of Stage III nonsmall cell lung carcinoma (NSCLC). This trial was conducted to evaluate the tolerance and responses of patients with NSCLC given a neoadjuvant regimen of cisplatin and vinorelbine chemotherapy